论文部分内容阅读
Negative Node Count Improvement Prognostic Predication of the Seventh Edition of the TNM Classificat
【机 构】
：
Department of Gastric Cancer Surgery,Tianjin Medical University Cancer Hospital and City Key Laborat
【出 处】
：
第8届全国胃癌学术会议暨首届阳光长城肿瘤学术会议
【发表日期】
：
2013年12期
其他文献
目的 探讨肠内营养对老年直肠癌患者术后胃肠功能紊乱的预防.方法 对50例老年行直肠癌根治术患者按随机数字表法分为2组：试验组和对照组,每组25例.试验组术前3d采用短肽型肠内营养剂替代传统流质饮食,术前禁食12h,禁水4h,术前常规清洁灌肠；对照组术前3d采用传统流质饮食(米汤、粥、菜汤等),术前禁食12h,术前常规清洁灌肠.2组患者术前2d均常规口服肠道抗生素.观察2组患者术中肠道清洁度、术后有
会议
Comparison of quality of life and nutritional parameters after total gastrectomy with or without jej
Objective To investigate the optimal reconstruction technique after total gastrectomy.Methods A total of 204patients with gastric cancer undergoing tatal gastrectomy in Tianjin Cancer Hosptital: group
腹腔镜手术方式的出现和推广应用，革命性地改变了传统的开放性手术方式。一时之间，腹腔镜辅助手术成为微创手术的代名词。经过了20多年的发展，腹腔镜辅助胃切除这种手术方式几乎已经成为外科治疗胃癌的常规选择。然而，在更复杂的手术过程中，腹腔镜手术方法其固有的弊端禁锢了它的进步。机器人辅助手术系统就是为了推动微创手术的进一步发展而设计，三维立体画面、仿真机械手腕以及震颤过滤等突破性功能的发明被认为可以填补腹
The significance of No.13 lymph node dissection in D2 gastrectomy for lower-third advanced gastric c
Objective: This study aimed to evaluate the feasibility and necessity of No.13 lymph node dissection in D2 radical gastrectomy for lower-third advanced gastric cancer(AGC).Methods: Data of 379 cases w
会议
The RML stage of lymph node metastasis was the most appropriate category for Evaluation overall surv
Objective: The aim of the study was to investigate N stage (according to the 7th edition UICC/AJCC TNM Classification for Gastric Cancer), ratio between metastatic and examined lymph nodes (RML) stage
The effect of extensive lymphadenectomy and post operation chemotherapy on patients with node negati
Aims: To evaluate the therapeutic value of extensive lymphadenectomy and post operation chemotherapy in patients with node negative gastric cancer is controversial.Methods: Clinical data of 311 patien
会议
Prospective Efficacy Evaluation of Intensity-modulated radiotherapy (IMRT) combined with Capecitabin
Purpose In RTOG0114 trial, 2-year disease-free survival (DFS) of taxol-based regimen failed to exceed lower bound of 52.9% and can t be recommended for future trial.We analyze 2 year results to evalua
会议
目的：明确胃癌合并贫血对患者生活质量、疗效、生存的影响，探讨胃癌合并贫血的关键病机以及中医药治疗胃癌合并贫血的机制、辨证立法与方药，以此为基础开展多中心临床研究，提供可推广的胃癌合并贫血中医药治疗方案.方法：胃癌合并贫血文献复习结合长期临床实践，探讨胃癌合并贫血的中医病机关键以及中医药治疗的辨证立法与方药.结果：晚期胃癌患者贫血发生率高达84.4％，患者因贫血影响生活质量、化疗疗效以及远期生存.目